XML 75 R55.htm IDEA: XBRL DOCUMENT
v3.20.2

Fair Value Measurements - Financial Instruments at Fair Value (Details) - USD ($) $ in Millions | Sep. 26, 2020 | Dec. 31, 2019
--- | --- | ---
Measured at fair value on a non-recurring basis: |  |  |
Goodwill carrying amount |  | $ 3,839.3 | $ 4,116.7
Definite-lived intangible assets carrying value |  | 2,895.4 | 2,921.2
Measured at fair value on a recurring basis | Level 1 |  |  |
Assets: |  |  |
Investment securities |  | 3.3 | 6.6
Foreign currency forward contracts |  | 0.0 | 0.0
Cross-currency swap |  | 0.0 | 0.0
Funds associated with Israeli severance liability |  | 0.0 | 0.0
Royalty Pharma contingent milestone |  | 0.0 | 0.0
Total assets |  | 3.3 | 6.6
Liabilities: |  |  |
Foreign currency forward contracts |  | 0.0 | 0.0
Contingent consideration |  | 0.0 | 0.0
Total liabilities |  | 0.0 | 0.0
Measured at fair value on a recurring basis | Level 2 |  |  |
Assets: |  |  |
Investment securities |  | 0.0 | 0.0
Foreign currency forward contracts |  | 8.7 | 4.3
Cross-currency swap |  | 7.7 | 26.3
Funds associated with Israeli severance liability |  | 14.2 | 14.6
Royalty Pharma contingent milestone |  | 0.0 | 0.0
Total assets |  | 30.6 | 45.2
Liabilities: |  |  |
Foreign currency forward contracts |  | 8.8 | 8.4
Contingent consideration |  | 0.0 | 0.0
Total liabilities |  | 8.8 | 8.4
Measured at fair value on a recurring basis | Level 3 |  |  |
Assets: |  |  |
Investment securities |  | 0.0 | 0.0
Foreign currency forward contracts |  | 0.0 | 0.0
Cross-currency swap |  | 0.0 | 0.0
Funds associated with Israeli severance liability |  | 0.0 | 0.0
Royalty Pharma contingent milestone |  | 121.2 | 95.3
Total assets |  | 121.2 | 95.3
Liabilities: |  |  |
Foreign currency forward contracts |  | 0.0 | 0.0
Contingent consideration |  | 12.8 | 11.9
Total liabilities |  | 12.8 | 11.9
Measured at fair value on a non-recurring basis |  |  |
Measured at fair value on a non-recurring basis: |  |  |
Definite-lived intangible assets carrying value |  |  | 55.3
Measured at fair value on a non-recurring basis | Level 1 |  |  |
Assets: |  |  |
Total assets |  | 0.0 | 0.0
Measured at fair value on a non-recurring basis: |  |  |
Goodwill | [1] | 0.0 | 0.0
Definite-lived intangible assets | [2] | 0.0 | 0.0
Measured at fair value on a non-recurring basis | Level 2 |  |  |
Assets: |  |  |
Total assets |  | 0.0 | 0.0
Measured at fair value on a non-recurring basis: |  |  |
Goodwill | [1] | 0.0 | 0.0
Definite-lived intangible assets | [2] | 0.0 | 0.0
Measured at fair value on a non-recurring basis | Level 3 |  |  |
Assets: |  |  |
Total assets |  | 811.1 | 1,036.4
Measured at fair value on a non-recurring basis: |  |  |
Goodwill | [1] | 811.1 | 1,013.1
Definite-lived intangible assets | [2] | 0.0 | 23.3
RX |  |  |
Measured at fair value on a non-recurring basis: |  |  |
Goodwill carrying amount | [3] | 811.1 | 1,013.9
RX | Measured at fair value on a non-recurring basis |  |  |
Measured at fair value on a non-recurring basis: |  |  |
Goodwill carrying amount |  | $ 1,013.5 | $ 1,122.3
[1] | During the three months ended September 26, 2020, goodwill with a carrying amount of $1,013.5 million was written down to a fair value of $811.1 million. During the year ended December 31, 2019, goodwill with a carrying amount of $1,122.3 million was written down to a fair value of $1,013.1 million.
[2] | During the year ended December 31, 2019, definite-lived intangible assets with a carrying amount of $55.3 million were written down to a fair value of $23.3 million.
[3] | We had accumulated goodwill impairments of $109.2 million and $311.6 million as of December 31, 2019 and September 26, 2020

X
- Definition Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Unobservable Input Reconciliation [Abstract] + References No definition available. + Details
Name: | prgo_FairValueAssetsandLiabilitiesMeasuredonNonrecurringBasisUnobservableInputReconciliationAbstract
Namespace Prefix: | prgo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Funds Associated With Israeli Post Employment Benefits Fair Value Disclosure + References No definition available. + Details
Name: | prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure
Namespace Prefix: | prgo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Potential Contingent Milestone Payments + References No definition available. + Details
Name: | prgo_PotentialContingentMilestonePayments
Namespace Prefix: | prgo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_AssetsFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_AssetsFairValueDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 35 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 926 -SubTopic 20 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value as of the balance sheet date of all foreign currency derivative assets designated as cash flow hedging instruments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959 + Details
Name: | us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959 + Details
Name: | us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps. + References No definition available. + Details
Name: | us-gaap_ForeignCurrencyContractAssetFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(10)(1)) -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266 + Details
Name: | us-gaap_Goodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_GoodwillFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_InvestmentsFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of financial and nonfinancial obligations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_LiabilitiesFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_LiabilitiesFairValueDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=prgo_RXPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |